NUCLEUS SOFTWARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 6,345 | 8,265 | 30.3% |
Other income | Rs m | 341 | 509 | 49.4% |
Total Revenues | Rs m | 6,685 | 8,774 | 31.2% |
Gross profit | Rs m | 1,568 | 2,204 | 40.6% |
Depreciation | Rs m | 187 | 146 | -22.3% |
Interest | Rs m | 10 | 10 | -6.9% |
Profit before tax | Rs m | 1,711 | 2,558 | 49.5% |
Tax | Rs m | 433 | 642 | 48.3% |
Profit after tax | Rs m | 1,278 | 1,916 | 49.9% |
Gross profit margin | % | 24.7 | 26.7 | |
Effective tax rate | % | 25.3 | 25.1 | |
Net profit margin | % | 20.1 | 23.2 |
Don't Miss: Key Information for Long-term Investors
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Networth | Rs m | 6,107 | 7,774 | 27.3 |
Current Liabilities | Rs m | 2,330 | 2,953 | 26.7 |
Long-term Debt | Rs m | 0 | 0 | 0.0 |
Total Liabilities | Rs m | 8,742 | 11,140 | 27.4 |
Current assets | Rs m | 4,834 | 6,118 | 26.5 |
Fixed Assets | Rs m | 3,908 | 5,023 | 28.5 |
Total Assets | Rs m | 8,742 | 11,140 | 27.4 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-23 | Mar-24 | ||
Cash Flow from Operating Activities | Rs m | 498 | 2,220 | 345.5% |
Cash Flow from Investing Activities | Rs m | -127 | -1,970 | - |
Cash Flow from Financing Activities | Rs m | -227 | -302 | - |
Net Cash Flow | Rs m | 147 | -47 | - |
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 237.0 | 308.7 |
TTM Earnings per share | Rs | 47.7 | 71.6 |
Diluted earnings per share | Rs | 47.7 | 71.6 |
Price to Cash Flow | x | 11.7 | 15.6 |
TTM P/E ratio | x | 13.4 | 20.0 |
Price / Book Value ratio | x | 2.2 | 4.1 |
Market Cap | Rs m | 13,698 | 32,194 |
Dividends per share (Unadj.) | Rs | 10.0 | 12.5 |
Current Ratio: The company's current ratio deteriorated and stood at 2.1x during FY24, from 2.1x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 270.3x during FY24, from 168.7x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company improved and stood at 24.6% during FY24, from 20.9% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 33.0% during FY24, from 28.2% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company improved and stood at 17.3% during FY24, from 14.7% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Current ratio | x | 2.1 | 2.1 |
Debtors’ Days | Days | 1,005 | 734 |
Interest coverage | x | 168.7 | 270.3 |
Debt to equity ratio | x | 0.0 | 0.0 |
Return on assets | % | 14.7 | 17.3 |
Return on equity | % | 20.9 | 24.6 |
Return on capital employed | % | 28.2 | 33.0 |
To see how NUCLEUS SOFTWARE has performed over the last 5 years, please visit here.
Over the last one year, NUCLEUS SOFTWARE share price has moved up from Rs 1,025.8 to Rs 1,431.0, registering a gain of Rs 405.3 or around 39.5%.
Meanwhile, the S&P BSE IT Index is trading at Rs 36,158.6 (down 0.0%). Over the last one year it has moved up from 28,855.0 to 36,158.6, a gain of 7,304 points (up 25.3%).
Overall, the S&P BSE SENSEX is up 21.8% over the year.
(To know more, check out historical annual results for NUCLEUS SOFTWARE and quarterly results for NUCLEUS SOFTWARE)
NUCLEUS SOFTWARE currently trades at Rs 1,069.1 per share. You can check out the latest share price performance of NUCLEUS SOFTWARE here...
The revenues of NUCLEUS SOFTWARE stood at Rs 8,774 m in FY24, which was up 31.2% compared to Rs 6,685 m reported in FY23.
NUCLEUS SOFTWARE's revenue has grown from Rs 5,581 m in FY20 to Rs 8,774 m in FY24.
Over the past 5 years, the revenue of NUCLEUS SOFTWARE has grown at a CAGR of 12.0%.
The net profit of NUCLEUS SOFTWARE stood at Rs 1,916 m in FY24, which was up 49.9% compared to Rs 1,278 m reported in FY23.
This compares to a net profit of Rs 409 m in FY22 and a net profit of Rs 1,180 m in FY21.
Over the past 5 years, NUCLEUS SOFTWARE net profit has grown at a CAGR of 21.1%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of NUCLEUS SOFTWARE reveals:
Here's the cash flow statement of NUCLEUS SOFTWARE for the past 5 years.
(Rs m) | FY20 | FY21 | FY22 | FY23 | FY24 |
---|---|---|---|---|---|
From Operations | 747 | 1,149 | 577 | 498 | 2,220 |
From Investments | -291 | -1,257 | 1,585 | -127 | -1,970 |
From Financial Activity | -341 | -133 | -2,129 | -227 | -302 |
Net Cashflow | 123 | -245 | 35 | 147 | -47 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of NUCLEUS SOFTWARE reveals:
Here's the ratio/financial analysis of NUCLEUS SOFTWARE for the past 5 years.
FY20 | FY21 | FY22 | FY23 | FY24 | |
---|---|---|---|---|---|
Operating Profit Margin (%) | 18.1 | 24.5 | 7.4 | 24.7 | 26.7 |
Net Profit Margin (%) | 17.1 | 23.0 | 8.2 | 20.1 | 23.2 |
Debt to Equity Ratio (x) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Equitymaster requests your view! Post a comment on "NUCLEUS SOFTWARE 2023-24 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!